Senhwa Biosciences, Inc. (TPEX:6492)

Senhwa Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4,049	4,540	5,140	9,329	20,164	4,804
Market Cap Growth	27.31%	-11.69%	-44.90%	-53.73%	319.76%	-10.35%
Enterprise Value	2,977	3,169	3,440	7,207	17,707	3,896
Last Close Price	45.40	50.90	58.00	104.00	225.00	63.12
Forward PE	-	-	-	9.83	142.41	-
PS Ratio	4851.72	4539.57	5140.42	16962.14	32680.84	16012.34
PB Ratio	3.66	3.45	3.18	4.74	8.67	5.80
P/TBV Ratio	4.39	3.45	3.18	4.74	8.67	5.80
EV/Sales Ratio	3704.26	3169.23	3440.18	13103.10	28698.35	12987.53
Debt / Equity Ratio	0.02	0.01	0.01	0.01	0.01	0.01
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Quick Ratio	40.06	31.24	49.40	24.80	38.76	28.75
Current Ratio	40.38	31.40	49.69	24.87	38.90	28.97
Return on Equity (ROE)	-23.69%	-20.22%	-19.52%	-15.33%	-22.50%	-38.41%
Return on Assets (ROA)	-15.10%	-12.88%	-11.98%	-9.71%	-13.80%	-23.38%
Return on Capital (ROIC)	-15.30%	-13.15%	-12.31%	-10.00%	-14.12%	-24.07%
Earnings Yield	-7.34%	-6.53%	-6.80%	-3.53%	-1.76%	-8.15%
FCF Yield	-7.01%	-6.41%	-7.79%	-3.22%	-1.35%	-8.01%
Buyback Yield / Dilution	0.00%	0.00%	0.50%	-13.49%	-6.06%	-0.07%
Total Shareholder Return	0.00%	0.00%	0.50%	-13.49%	-6.06%	-0.07%

Source: S&P Capital IQ. Standard template. Financial Sources.